Key result
Inhibition of coagulation factors or protease-activated receptors ameliorates inflammation and kidney injury in eNOS-deficient diabetic mouse models.
Why the study?
To summarize the relationship between eNOS, coagulation, and PARs and propose a novel therapeutic option for the management of patients with DKD.
Inhibition of coagulation factors or PARs may represent a novel therapeutic option for managing inflammation in diabetic kidney disease, based on evidence from eNOS-deficient mice.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for coagulation inhibition in diabetic kidney disease; should not yet change clinical practice.
Endothelial nitric oxide synthase (eNOS) dysfunction is known to exacerbate the progression and prognosis of diabetic kidney disease (DKD). One of the mechanisms through which this is achieved is that low eNOS levels are associated with hypercoagulability, which promotes kidney injury. In the extrinsic coagulation cascade, the tissue factor (factor III) and downstream coagulation factors, such as active factor X (FXa), exacerbate inflammation through activation of the protease-activated receptors (PARs). Recently, it has been shown that the lack of or reduced eNOS expression in diabetic mice, as a model of advanced DKD, increases renal tissue factor levels and PAR1 and 2 expression in their kidneys. Furthermore, pharmaceutical inhibition or genetic deletion of coagulation factors or PARs ameliorated inflammation in DKD in mice lacking eNOS. In this review, we summarize the relationship between eNOS, coagulation, and PARs and propose a novel therapeutic option for the management of patients with DKD.
No takes yet. Share an insight, caveat, or question.
Oe et al. (2021) conducted a review in Diabetic Kidney Disease. Coagulation factor and PAR inhibition was evaluated. Inhibition of coagulation factors or protease-activated receptors ameliorates inflammation and kidney injury in eNOS-deficient diabetic mouse models.
Synapse has enriched 10 related papers. Consider them for comparative context: